[
Abd-Elbaky AE, Abo-ElMatty DM, Mesbah NM, Ibrahim SM. Associations of serum omentin and apelin concentrations with obesity, diabetes mellitus type 2 and cardiovascular diseases in Egyptian population. Endocrinol Metab Synd 4, 1000171, 2015.
]Search in Google Scholar
[
Ali S, Alam R, Ahsan H, Khan S. Role of adipokines (omentin and visfatin) in coronary artery disease. Nutrition Metabol Cardiovasc Disease 33, 483–493, 2023.
]Search in Google Scholar
[
Biscetti F, Nardella E, Rando MM, Cecchini AL, Angelini F, Cina A, Iezzi R, Filipponi M, Santoliquido A, Pitocco D, Landolfi R, Flex A. Association between omentin-1 and major cardiovascular events after lower extremity endovascular revascularization in diabetic patients: a prospective cohort study. Cardiovasc Diabetol 19, 170, 2020.
]Search in Google Scholar
[
Cordido F, Garcia-Mayorb RV, Larranagab A. Obesity, adipose tissue, inflammation and update on obesity page 2 of 8 managements. Obes Control Ther 1, 1–8, 2014.
]Search in Google Scholar
[
Dahl TB, Yndestad A, Skjelland M, Oie E, Dahl A, Michelsen A, Damas JK, Tunheim SH, Ueland T, Smith C, Bendz B, Tonstad S, Gullestad L, Froland SS, Krohg-Sorensen K, Russell D, Aukrust P, Halvorsen B. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization. Circulation 115, 972–980, 2007.
]Search in Google Scholar
[
De Luis DA, Sagrado MG, Conde R, Aller R, Izaola O, Castro MJ, Romero E. Lack of effect of a moderate hypocaloric diet on visfatin levels in morbid obese patients: relationship with insulin resistance. Eur Rev Med Pharmacol Sci 14, 1031–1036, 2010.
]Search in Google Scholar
[
de Souza Batista CM, Yang RZ, Lee MJ, Glynn NM, Yu DZ, Pray J, Ndubuizu K, Patil S, Schwartz A, Kligman M, Fried SK, Gong DW, Shuldiner AR, Pollin TI, McLenithan JC. Omentin plasma levels and gene expression are decreased in obesity. Diabetes 56, 1655–1661, 2007.
]Search in Google Scholar
[
Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, Watanabe E, Takagi T, Akiyoshi M, Ohtsubo T, Kihara S, Yamashita S, Makishima M, Funahashi T, Yamanaka S, Hiramatsu R, Matsuzawa Y, Shimomura I. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307, 426430, 2005.
]Search in Google Scholar
[
Goossens GH, Blaak EE. Adipose tissue dysfunction and impaired metabolic health in human obesity: a matter of oxygen? Front Endocrinol 6, 55, 2015.
]Search in Google Scholar
[
GTExPortal. Available from https://gtexportal.org/home/2019.
]Search in Google Scholar
[
Herder C, Carstensen M, Ouwens DM. Anti-inflammatory cytokines and risk of type 2 diabetes. Diabetes Obes Metab 15, 39–50, 2013.
]Search in Google Scholar
[
Herder C, Ouwens DM, Carstensen M, Kowall B, Huth C, Meisinger C, Rathmann W, Roden M, Thorand B. Adiponectin may mediate the association between omentin, circulating lipids and insulin sensitivity: results from the KORA F4 study. Eur J Endocrinol 172, 423–432, 2015.
]Search in Google Scholar
[
Herder C, Kannenberg JM, Niersmann C, Huth C, Carstensen-Kirberg M, Wittenbecher C, Schulze M, Bluher M, Rathmann W, Peters A, Roden M, Meisinger C, Thorand B. Independent and opposite associations of serum levels of omentin-1 and adiponectin with increases of glycemia and incident type 2 diabetes in an older population: KORA F4/FF4 study. Eur J Endocrinol 177, 277–286, 2017.
]Search in Google Scholar
[
Hiramatsu-Ito M, Shibata R, Ohashi K. Uemura Y, Kanemura N, Kambara T, Enomoto T, Yuasa D, Matsuo K, Ito M, Hayakawa S, Ogawa H, Otaka N, Kihara S, Murohara T, Ouchi N. Omentin attenuates atherosclerotic lesion formation in apolipoprotein E-deficient mice. Cardiovasc Res 110, 107–117, 2016.
]Search in Google Scholar
[
Jung CH, Jung SH, Kim BY, Kim CH, Kang SK, Mok JO. Association of serum omentin levels with cardiac autonomic neuropathy in patients with type 2 diabetes mellitus: a hospital-based study. Cardiovasc Diabetol 14, 140, 2015.
]Search in Google Scholar
[
Karberg K, Forbes A, Lember M. Visfatin and subclinical atherosclerosis in type 2 diabetes: Impact of cardiovascular drugs. Medicina 59, 1324, 2023.
]Search in Google Scholar
[
Kataoka Y, Shibata R, Ohashi K, Kambara T, Enomoto T, Uemura Y, Ogura Y, Yuasa D, Matsuo K, Nagata T, Oba T, Yasukawa H, Numaguchi Y, Sone T, Murohara T, Ouchi N. Omentin prevents myocardial ischemic injury through AMP-activated protein kinase-and Akt-dependent mechanisms. J Am Coll Cardiol 63, 2722–2733, 2014.
]Search in Google Scholar
[
Lago F, Dieguez C, Gomez-Reino J, Gualillo O. The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev 18, 313–325, 2007.
]Search in Google Scholar
[
Looker HC, Colombo M, Agakov F, Zeller T, Groop L, Thorand B, Palmer CN, Hamsten A, de Faire U, Nogoceke E, Livingstone SJ, Salomaa V, Leander K, Barbarini N, Bellazzi R, van Zuydam N, McKeigue PM, Colhoun HM. Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes. Diabetologia 58, 1363–1371, 2015.
]Search in Google Scholar
[
Malyszko J, Malyszko JS, Mysliwiec M. Visfatin and endothelial function in dialyzed patients. Nephrology (Carlton) 15, 190–196, 2010.
]Search in Google Scholar
[
Mattu HS, Randeva HS. Role of adipokines in cardiovascular disease. J. Endocrinol 216, T17–T36, 2013.
]Search in Google Scholar
[
Menzel J, di Giuseppe R, Biemann R, Wittenbecher C, Aleksandrova K, Pischon T, Fritsche A, Schulze MB, Boeing H, Isermann B, Weikert C. Omentin-1 and risk of myocardial infarction and stroke: results from the EPICPotsdam cohort study. Atherosclerosis 251, 415–421, 2016.
]Search in Google Scholar
[
Orlik B, Madej P, Owczarek A, Skalba P, Chudek J, Olszanecka-Glinianowicz M. Plasma omentin and adiponectin levels as markers of adipose tissue dysfunction in normal weight and obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 81, 529–535, 2014.
]Search in Google Scholar
[
Pan HY, Guo L, Li Q. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res Clin Pract 88, 29–33, 2010.
]Search in Google Scholar
[
Raucci R, Rusolo F, Sharma A, Colonna G, Castello G, Costantini S. Functional and structural features of adipokine family. Cytokine 61, 1–14, 2013.
]Search in Google Scholar
[
Romacho T, Sanchez-Ferrer CF, Peiro C. Visfatin/Nampt: an adipokine with cardiovascular impact. Cairo: Hindawi Publishing Corporation Mediators Inflamm 2013, 946427, 2013.
]Search in Google Scholar
[
Saely CH, Leiherer A, Muendlein A, Vonbank A, Rein P, Geiger K, Malin C, Drexel H. High plasma omentin predicts cardiovascular events independently from the presence and extent of angiographically determined atherosclerosis. Atherosclerosis 244, 38–43, 2016.
]Search in Google Scholar
[
Shibata R, Ouchi N, Kikuchi R, Takahashi R, Takeshita K, Kataoka Y, Ohashi K, Ikeda N, Kihara S, Murohara T. Circulating omentin is associated with coronary artery disease in men. Atherosclerosis 219, 811–814, 2011.
]Search in Google Scholar
[
Schottker B, Herder C, Rothenbacher D, Roden M, Kolb H, Muller H, Brenner H. Proinflammatory cytokines, adiponectin, and increased risk of primary cardiovascular events in diabetic patients with or without renal dysfunction: results from the ESTHER study. Diabetes Care 36, 1703–1711, 2013.
]Search in Google Scholar
[
Sonoli SS, Shivprasad S, Prasad CVB, Patil AB, Desai PB, Somannavar MS. Visfatin-a review. Eur Rev Med Pharmacol Sci 15, 9–14, 2011.
]Search in Google Scholar
[
Sperling M, Grzelak T, Pelczynska M, Bogdanski P, Formanowicz D, Czyzewska K. Association of serum omentin-1 concentration with the content of adipose tissue and glucose tolerance in subjects with central obesity. Biomedicines 11, 331, 2023.
]Search in Google Scholar
[
Tan BK, Adya R, Randeva HS. Omentin: a novel link between inflammation, diabesity, and cardiovascular disease. Trends Cardiovasc Med 20, 143–148 2010.
]Search in Google Scholar
[
Vu A, Sidhom MS, Bredbeck BC, Kosmiski LA, Aquilante CL. Evaluation of the relationship between circulating omentin-1 concentrations and components of the metabolic syndrome in adults without type 2 diabetes or cardiovascular disease. Diabetol Metab Syndr 6, 4, 2014.
]Search in Google Scholar
[
Wang Z, Nakayama T. Inflammation, a link between obesity and cardiovascular disease. Mediators Inflamm 2010, 535918, 2010.
]Search in Google Scholar
[
Watanabe K, Watanabe R, Konii H, Shirai R, Sato K, Matsuyama TA, Ishibashi-Ueda H, Koba S, Kobayashi Y, Hirano T, Watanabe T. Counteractive effects of omentin-1 against atherogenesis. Cardiovasc Res 110, 118128, 2016.
]Search in Google Scholar
[
Wittenbecher C, Menzel J, Carstensen-Kirberg M, Biemann R, di Giuseppe R, Fritsche A, Isermann B, Herder C, Aleksandrova K, Boeing H, Weikert C, Schulze MB. Omentin-1, adiponectin, and the risk of developing type 2 diabetes. Diabetes Care 39, e79–e80, 2016.
]Search in Google Scholar
[
Xu F, Ning X, Zhao T, Lu Q, Chen H. Visfatin is negatively associated with coronary artery lesions in subjects with impaired fasting glucose. Open Med 17, 1405–1411, 2022.
]Search in Google Scholar
[
Yan P, Liu D, Long M, Ren Y, Pang J, Li R. Changes of serum omentin levels and relationship between omentin and adiponectin concentrations in type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 119, 257–263, 2011.
]Search in Google Scholar
[
Yan Q, Zhang Y, Hong J, Gu W, Dai M, Shi J, Zhai Y, Wang W, Li X, Ning G. The association of serum chemerin level with risk of coronary artery disease in Chinese adults. Endocrine 41, 281e–288e, 2012.
]Search in Google Scholar
[
Yang RZ, Xu AH, Pray J, Hong H, Jadhao S, Hansen B, Shuldiner AR, McLenithan JC, Gong DW. Cloning of omen-tin, a new adipocytokine from omental fat tissue in humans. In: Diabetes 52, A1–A1, 2003.
]Search in Google Scholar
[
Yang RZ, Lee MJ, Hu H, Pray J, Wu HB, Hansen BC, Shuldiner AR, Fried SK, McLenithan JC, Gong DW. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab 290, E1253–E1261, 2006.
]Search in Google Scholar
[
Zakaria E, El-Rawi HODH, Ghanem NS, Elsayed NM, Rashed L, El-Tony E. Serum visfatin level in Egyptian diabetics with and without microvascular complications. Med J Cairo Univ 81, 411–415, 2013.
]Search in Google Scholar
[
Zhang Q, Zhu L, Zheng M. Fan C, Li Y, Zhang D, He Y, Yang H. Changes of serum omentin-1 levels in normal subjects, type 2 diabetes and type 2 diabetes with overweight and obesity in Chinese adults. Ann Endocrinol (Paris) 75, 171–175, 2014.
]Search in Google Scholar
